相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
1131626-47-5
- 规格:
10 mM * 1 mL///1 mg
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Gamitrinib TPP hexafluorophosphate
CAS No. : 1131626-47-5
MCE 国际站:Gamitrinib TPP hexafluorophosphate
产品活性:Gamitrinib TPP hexafluorophosphate 是一种 Gamitrinib (GA) 线粒体基质的抑制剂。Gamitrinib TPP hexafluorophosphate 是一种靶向线粒体的 HSP90 抑制剂。具有抗癌活性。
研究领域:Cell Cycle/DNA Damage | Metabolic Enzyme/Protease
作用靶点:HSP
In Vitro: Gamitrinib TPP (GamitrinibTPP, G-TPP), a small molecule that combines the Hsp90 ATPase inhibitory module of 17-allylamino geldanamycin (17-AAG) with the mitochondrial-targeting moiety of triphenylphosphonium. Gamitrinib TPP is selectively delivered to mitochondria and does not affect Hsp90 homeostasis outside the organelle. Within a 16-hour exposure, concentrations of Gamitrinib TPP of 15-20 μM indistinguishably kill patient-derived and cultured glioblastoma cell lines. This cell death response has the hallmarks of mitochondrial apoptosis, with loss of organelle inner membrane potential, release of cytochrome c in the cytosol, activation of initiator caspase-9 and effector caspase-3 and caspase-7, and cellular reactivity for annexin V.
In Vivo: Whether the combination of TRAIL plus Gamitrinib TPP (GamitrinibTPP, G-TPP) has activity against glioblastoma in vivo is studied. Luciferase-expressing U87 glioblastoma cells implanted in the right cerebral striatum of immunocompromised mice give rise to rapidly growing tumors by bioluminescence imaging, and treatment of these mice with vehicle, stereotactic delivery of TRAIL, or systemic administration of suboptimal concentrations of Gamitrinib TPP does not affect tumor growth in vivo. Similarly, systemic monotherapy with Gamitrinib TPP at concentrations (20 mg/kg as daily i.p. injections) that inhibit subcutaneous xenograft tumor growth in mice has no effect on orthotopic glioblastoma growth. In contrast, 2 cycles of intracranial TRAIL combined with systemic Gamitrinib TPP suppresses the growth of established glioblastomas, with no significant animal weight loss throughout treatment.
相关产品:Bioactive Compound Library Plus | Tamoxifen | Palmitic acid | Polyinosinic-polycytidylic acid | Tanespimycin | VER-155008 | Geldanamycin | Ganetespib | Rocaglamide | Luminespib | HA15 | Novobiocin sodium | Apoptozole | Paeoniflorin | Alvespimycin hydrochloride | DTHIB | Benzbromarone | Pimitespib | HSP27 inhibitor J2 | KRIBB11 | MKT-077 | Onalespib | Col003 | MK2-IN-1 hydrochloride | BIIB021 | Pifithrin-μ | Grp94 Inhibitor-1 | HSF1A | Teprenone | XL888
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验bp片段所组成.用这种方法作者能检出一些标本含有一条螺旋体的螺旋体DNA. 2、引物的设计部位与序列及其意义 目前有四套扩增梅毒螺旋体DNA的系统:扩增47KDa膜抗原基因(tpp47基因)、扩增39KDa碱性膜蛋白基因(bmp基因)、扩增TpF1蛋白基因(tpf-1)或TyF1蛋白基因(tyf-1)和扩增tmpA基因. 三种扩增系统的引物序列 系统引物 序列 位置 47-1 CACAATGCTCACTGAGGATAGT 648~
7-TerminatorpCAMBIA1301(1300)pCAMBIA1301-5'(ECORI)/M13RpCAMBIA1301-3'(HindIII)pCAMBIA1304pCAMBIA1301-5'(ECORI)pCAMBIA1301-3'(HindIII)pCAMBIA2300M13R(-48)M13F(-47)/M13F(-49)pCANTB5ES1S6pCAT3-enhancerRVP3此载体无反向引物pCDFDuet-1(MCSI)ACYCDuetUP1 PrimerDuetDOWN1pCDFDuet-1(MCSII
(1300) P1 P2 pCAMBIA 2300 M13R(-48) M13F(-47) PCANTB5E S1/M13R S6 pCAT3-enhancer RVP3 此载体无反向引物 pcDNA3.0 CMV-F/T7 SP6/BGH pcDNA3.1 T7 BGH pcDNA4 T7/CMV-F BGH pcDNA6 T7/CMV-F(J21025在T7前面) BGH pcDNAII T7 SP6 pCE2.1 M13F M13R pCEP4 pCEP-F EBV-R
技术资料暂无技术资料 索取技术资料


















